Progress Report on EMBED: A Pragmatic Trial of User-Centered Clinical Decision Support to Implement EMergency Department-Initiated BuprenorphinE for Opioid Use Disorder-Journal of Psychiatry and Brain Science-CSCIED科技核心评价数据库-手机版

Progress Report on EMBED: A Pragmatic Trial of User-Centered Clinical Decision Support to Implement EMergency Department-Initiated BuprenorphinE for Opioid Use Disorder

Progress Report on EMBED: A Pragmatic Trial of User-Centered Clinical Decision Support to Implement EMergency Department-Initiated BuprenorphinE for Opioid Use Disorder

ES评分 0 浏览量：1001 下载量：0

全文阅读下载引用收藏

DOI	10.20900/jpbs.20200003
刊名	Journal of Psychiatry and Brain Science JPBS
年，卷(期)	2020, 5(1)
作者	Edward R.Melnick*,Bidisha Nath,Osama M. Ahmed,Cynthia Brandt,David Chartash,James D. Dziura,Erik P. Hess,Wesley C. Holland,Jason A. Hoppe,Molly M. Jeffery,Liliya Katsovich,Fangyong Li,Charles C. Lu,Kaitlin Maciejewski,Matthew Maleska,Jodi A. Mao,Shara Mar,
作者单位	1 Department of Emergency Medicine, Yale University School of Medicine, New Haven, CT 06519, USA; 2 Yale University School of Medicine, New Haven, CT 06510, USA; 3 Yale Center for Medical Informatics, Yale University School of Medicine, New Haven, CT 06511, USA; 4 Yale Center for Analytical Sciences, Yale School of Public Health, New Haven, CT 06520, USA; 5 Department of Emergency Medicine, University of Alabama at Birmingham School of Medicine, Birmingham, AL 35233, USA; 6 Department of Emergency Medicine, University of Colorado, Aurora, CO 80045, USA; 7 Department of Emergency Medicine, Mayo Clinic, Rochester, MN 55905, USA; 8 The Patient Revolution, New Haven, CT 06511, USA; 9 Information Technology Services, Yale New-Haven Health, New Haven, CT 06519, USA; 10 Department of Emergency Medicine, University of North Carolina School of Medicine, Chapel Hill, NC 27599, USA; 11 Department of Emergency Medicine, University of Massachusetts Medical School-Baystate, Baystate, MA 01199, USA
Abstract	Buprenorphine (BUP) can safely and effectively reduce craving, overdose, and mortality rates in people with opioid use disorder (OUD). However, adoption of ED-initiation of BUP has been slow partly due to physician perception this practice is too complex and disruptive. We report progress of the ongoing EMBED (EMergency department-initiated BuprenorphinE for opioid use Disorder) project. This project is a five-year collaboration across five healthcare systems with the goal to develop, integrate, study, and disseminate user-centered Clinical Decision Support (CDS) to promote the adoption of Emergency Department (ED)-initiation of buprenorphine/naloxone (BUP) into routine emergency care. Soon to enter its third year, the project has already completed multiple milestones to achieve its goals including (1) user-centered design of the CDS prototype, (2) integration of the CDS into an automated electronic health record (EHR) workflow, (3) data coordination including derivation and validation of an EHR-based computable phenotype, (4) meeting all ethical and regulatory requirements to achieve a waiver of informed consent, (5) pilot testing of the intervention at a single site, and (6) launching a parallel group-randomized 18-month pragmatic trial in 20 EDs across 5 healthcare systems. Pilot testing of the intervention in a single ED was associated with increased rates of ED-initiated BUP and naloxone prescribing and a doubling of the number of unique physicians adopting the practice. The ongoing multi-center pragmatic trial will assess the intervention’s effectiveness, scalability, and generalizability with a goal to shift the emergency care paradigm for OUD towards early identification and treatment.Trial Registration: Clinicaltrials.gov # NCT03658642.
KeyWord	user-centered design; clinical decision support systems; opioid-related disorders; opioid use disorder; buprenorphine; health information technology; electronic health records; health informatics; quality improvement; medication for opioid use disorder (M
基金项目
页码	-

参考文献
相关文献

1.Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and opioid overdose deaths—United States, 2000–2014. Morb Mortal Wkly Rep. 2016;64:1378-82.

2.Buchanich JM, Balmert LC, Burke DS. Exponential Growth of The USA Overdose Epidemic. bioRxiv 39961
[Preprint]. 2017. https://doi.org/10.1101/134403

3.Centers for Disease Control and Prevention. 2018 Annual Surveillance Report of Drug-Related Risks and Outcomes—United States. Surveillance Special Report. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services. Available from: https://www.cdc.gov/drugoverdose/pdf/pubs/2018-cdc-drug-surveillance-report.pdf. Accessed 2020 Feb 20.

4.Seth P, Scholl L, Rudd RA, Bacon S. Overdose deaths involving opioids, cocaine, and psychostimulants—United States, 2015–2016. Morb Mortal Wkly Rep. 2018;67:349-58.

5.Substance Abuse and Mental Health Services Administration. Drug Abuse Warning Network. 2011: National Estimates of Drug-Related Emergency Department Visits. Available from: http://www.samhsa.gov/data/sites/default/files/DAWN2k11ED/DAWN2k11ED/DAWN2k11ED.pdf. Accessed 2020 Feb 20.

6.Vivolo-Kantor AM, Seth P, Gladden RM, et al. Vital signs: trends in emergency department visits for suspected opioid overdoses—United States, July 2016–September 2017. Morb Mortal Wkly Rep. 2018;67:279-85.

7.Weiner SG, Baker O, Bernson D, Schuur JD. One-Year Mortality of Patients after Emergency Department Treatment for Nonfatal Opioid Overdose. Ann Emerg Med. 2020;75(1):13-7. https://doi.org/10.1016/j.annemergmed.2019.04.020

8.sDʼOnofrio G, McCormack RP, Hawk K. Emergency Departments—A 24/7/365 Option for Combating. N Engl J Med. 2018;379(26):2487-90. doi: 10.1056/NEJMp1811988

9.Sullivan LE, Fiellin DA. Narrative review: buprenorphine for opioid-dependent patients in office practice. Ann Intern Med. 2008;148:662-70.

10.Larochelle MR, Liebschutz JM, Zhang F, Ross-Degnan D, Wharam JF. Opioid prescribing after nonfatal overdose and association with repeated overdose. Ann Intern Med. 2016;165(5):376-7. doi: 10.7326/L16-0168

11.Mattick RP. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2003;(2):CD002207. doi: 10.1002/14651858.CD002207.pub4

12.Kakko J. 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in sweden: A randomised, placebo-controlled trial. Lancet. 2003;361(9358):662-8. doi: 10.1016/S0140-6736(03)12600-1

13.Weiss RD, Potter JS, Fiellin DA, Byrne M, Connery HS, Dickinson W, et al. Adjunctive Counseling during Brief and Extended Buprenorphine-Naloxone Treatment for Prescription Opioid Dependence. Arch Gen Psychiatry. 2011;68(12):1238-46. doi: 10.1001/archgenpsychiatry.2011.121

14.Substance Abuse and Mental Health Services Administration, U.S. Department of Health and Human Services. The National Survey on Drug Use and Health: 2018. Available from: https://www.samhsa.gov/data/release/2018-national-survey-drug-use-and-health-nsduh-releases. Accessed 2020 Feb 20.

15.DʼOnofrio G, OʼConnor PG, Pantalon MV, Chawarski MC, Busch SH, Owens PH, et al. Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial. JAMA. 2015;313:1636-44.

16.Duber HC, Barata IA, Cioè-Peña E, Liang SY, Ketcham E, Macias-Konstantopoulos W, et al. Identification, management, and transition of care for patients with opioid use disorder in the emergency department. Ann Emerg Med. 2018;72(4):420-31. doi: 10.1016/j.annemergmed.2018.04.007

17.Martin A, Mitchell A, Wakeman S, White B, Raja A. Emergency department treatment of opioid addiction: an opportunity to lead. Acad Emerg Med. 2018;25(5):601-4. doi: 10.1111/acem.13367

18.Lowenstein M, Kilaru A, Perrone J, Hemmons J, Abdel-Rahman D, Meisel ZF, et al. Barriers and facilitators for emergency department initiation of buprenorphine: A physician survey. Am J Emerg Med. 2019;37(9):1787-90. doi: 10.1016/j.ajem.2019.02.025

19.Melnick ER, Dyrbye LN, Sinsky CA, Trockel M, West C, Nedelec L, et al. The Association Between Perceived Electronic Health Record Usability and Professional Burnout among US Physicians. Mayo Clinic Proc. 2019. https://doi.org/10.1016/j.mayocp.2019.09.024b

20.Melnick ER, Jeffery MM, Dziura JD, Mao JA, Hess EP, Platts-Mills TF, et al. User-centred clinical decision support to implement emergency department-initiated buprenorphine for opioid use disorder: protocol for the pragmatic group randomized EMBED trial. BMJ Open. 2019;9(5):e028488. doi: 10.1136/bmjopen-2018-028488

21.Ray JM, Ahmed OM, Solad Y, Maleska M, Martel S, Jeffery MM, et al. Computerized Clinical Decision Support System for Emergency Department–Initiated Buprenorphine for Opioid Use Disorder: User-Centered Design. JMIR Hum Factors. 2019;6(1):e13121. doi: 10.2196/13121

22.Chartash D, Paek H, Dziura JD, Ross BK, Nogee DP, Boccio E, et al. Identifying Opioid Use Disorder in the Emergency Department: Multi-System Electronic Health Record–Based Computable Phenotype Derivation and Validation Study JMIR Med Inform. 2019;7(4):e15794. doi: 10.2196/15794

23.Ahmed OM, Mao JA, Holt SR, Hawk K, DʼOnofrio G, Martel S, et al. A scalable, automated warm handoff from the emergency department to community sites offering continued medication for opioid use disorder: Lessons learned from the EMBED trial stakeholders, J Subst Abuse Treat. 2019;102:47-52. doi: 10.1016/j.jsat.2019.05.006

24.Melnick ER, Holland WC, Ahmed OM, Ma AK, Michael SS, Goldberg HS, et al. An integrated web application for decision support and automation of EHR workflow: a case study of current challenges to standards-based messaging and scalability from the EMBED trial. JAMIA Open. 2019;2(4):434-9. doi: 10.1093/jamiaopen/ooz053

25.Campbell RJ. The Five Rights of Clinical Decision Support: CDS Tools Helpful for Meeting Meaningful Use. J AHIMA. 2013;84:42-7.

26.Murthy VH. Ending the Opioid Epidemic—A Call to Action. N Engl J Med. 2016;375(25):2413-5. doi: 10.1056/NEJMp1612578

27.Dearing JW, Cox JG. Diffusion of Innovations Theory, Principles, and Practice. Health Aff. 2018;37(2):183-90.

28.Link BG, Yang LH, Phelan JC, Collins PY. Measuring mental illness stigma. Schizophrenia Bull. 2004;30(3):511-41.

引用本文

Edward R.Melnick*,Bidisha Nath,Osama M. Ahmed,Cynthia Brandt,David Chartash,James D. Dziura,Erik P. Hess,Wesley C. Holland,Jason A. Hoppe,Molly M. Jeffery,Liliya Katsovich,Fangyong Li,Charles C. Lu,Kaitlin Maciejewski,Matthew Maleska,Jodi A. Mao,Shara Mar. Progress Report on EMBED: A Pragmatic Trial of User-Centered Clinical Decision Support to Implement EMergency Department-Initiated BuprenorphinE for Opioid Use Disorder, Journal of Psychiatry and Brain Science. 2020; 5; (1). https://doi.org/10.20900/jpbs.20200003.

文献评论

相关学者

相关机构